Key result
Fat-infiltrated axillary lymph nodes visualized on screening mammograms were significantly associated with a higher prevalence of type 2 diabetes mellitus (OR 3.92).
Why the study?
Ectopic fat deposition predicts cardiometabolic disease better than BMI, but fat deposition within the lymphatic system is poorly understood.
Does the presence of fat-infiltrated axillary lymph nodes on screening mammography associate with cardiometabolic disease in women?
Cross-Sectional (n=834)
No
Does the presence of fat-infiltrated axillary lymph nodes on screening mammography associate with cardiometabolic disease in women?
Odds Ratio: 3.92 (95% CI 2.4–6.6)
Absolute Event Rate: 19% vs 5.6%
p-value: p=< 0.001
Fat-infiltrated axillary lymph nodes identified on routine screening mammography may serve as a novel imaging biomarker for type 2 diabetes mellitus.
May flag higher T2DM risk on routine mammography; hypothesis-generating and requires prospective validation before clinical use.
Objective Ectopic fat deposition within and around organs is a stronger predictor of cardiometabolic disease status than body mass index. Fat deposition within the lymphatic system is poorly understood. This study examined the association between the prevalence of cardiometabolic disease and ectopic fat deposition within axillary lymph nodes (LNs) visualized on screening mammograms. Methods A cross-sectional study was conducted on 834 women presenting for full-field digital screening mammography. The status of fat-infiltrated LNs was assessed based on the size and morphology of axillary LNs from screening mammograms. The prevalence of cardiometabolic disease was retrieved from the electronic medical records, including type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, high blood glucose, cardiovascular disease, stroke, and non-alcoholic fatty liver disease. Results Fat-infiltrated axillary LNs were associated with a high prevalence of T2DM among all women (adjusted odds ratio: 3.92, 95% CI: [2.40, 6.60], p-value < 0.001) and in subgroups of women with and without obesity. Utilizing the status of fatty LNs improved the classification of T2DM status in addition to age and BMI (1.4% improvement in the area under the receiver operating characteristic curve). Conclusion Fat-infiltrated axillary LNs visualized on screening mammograms were associated with the prevalence of T2DM. If further validated, fat-infiltrated axillary LNs may represent a novel imaging biomarker of T2DM in women undergoing screening mammography.
No takes yet. Share an insight, caveat, or question.
Song et al. (2021) conducted a cross-sectional in Cardiometabolic disease (n=834). Fat-infiltrated axillary lymph nodes vs. Normal axillary lymph nodes was evaluated on Prevalence of type 2 diabetes mellitus (T2DM) (OR 3.92, 95% CI 2.40, 6.60, p=< 0.001). Fat-infiltrated axillary lymph nodes visualized on screening mammograms were significantly associated with a higher prevalence of type 2 diabetes mellitus (OR 3.92).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: